Drug
Disufenton sodium clinical trials
Also written OKN-007 and NXY-059.
How studies write it
Studies that test it under each name
Studies by the year they started
6 studies that test it; most in 2003 (2)
| Year | Studies |
|---|---|
| 2003 | 2 |
| 2004 | 1 |
| 2012 | 1 |
| 2020 | 1 |
| 2022 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 0
Oblato, Inc. (3) · AstraZeneca (3)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses disufenton sodium is read from its arms, and is right about nine times in ten.
Testing it · 6
- Open-label Study Investigating of OKN-007 Combined With Temozolomide in Patients With Recurrent GlioblastomaCompletedPhase 2Oblato, Inc.NCT04388475Written as OKN-007
- Clinical Trial of IV OKN-007 in a Pilot Cohort of Human Recurrent Malignant Glioma PatientsStatus unknownPhase 1Oblato, Inc.NCT01672463Written as OKN-007
- Investigation of Oral OKN-007 in Recurrent High-grade Glioma ParticipantsWithdrawnPhase 1/2Oblato, Inc.NCT03649464Written as OKN-007
- Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCompletedPhase 2AstraZenecaNCT00075959Written as NXY-059
- Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCompletedPhase 3AstraZenecaNCT00119626Written as NXY-059
- Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a StrokeCompletedPhase 3AstraZenecaNCT00061022Written as NXY-059
Given in every arm · 1 — disufenton sodium is usual care beside what is tested
Codes
What other systems call disufenton sodium · ClinicalTrials.gg INT004175
- MeSH (NLM) C120851disufenton sodiumConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 7M1J3HN9VODISUFENTON SODIUMConfirmed FDA, NLM, Wikidata
- Wikidata Q5283598Disufenton sodiumConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C77600Disufenton SodiumOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C120851 | disufenton sodium | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 7M1J3HN9VO | DISUFENTON SODIUM | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q5283598 | Disufenton sodium | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C77600 | Disufenton Sodium | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.